Sunday’s Boston Globe put on the pom-poms for the city’s role “as a hotbed for life sciences” in advance of the Biotechnology Industry Organization convention’s opening today.
As biotech giants convene, Massachusetts stands out
Biotech talent flows Boston’s way
Some venture firms find both ideas and the money
Leave it to Monday’s Boston Herald to be the skunk at the garden party:
Massachusetts has added more than 4,000 life sciences jobs since Gov. Deval Patrick announced his billion-dollar initiative in 2007 — the last time Boston hosted the international BIO convention — but many say the state’s investment, $302 million so far, hasn’t generated a big enough return, and competition from other regions, especially New York, is heating up.
New York’s biotech cluster receives $1.4 billion in National Institutes of Health funding, second only to Boston, said Kristy Syndjaja, who heads the New York City Industry Transformation Department. The city is hosting a November conference featuring top Hub life science CEOs and venture capitalists.
The Big Apple is already home to the Alexandria Center for Life Science, the New York Genome Center, nine academic medical centers and 75 percent more medical students, Syndjaja said. While Boston is looking to expand its life sciences super-cluster and attract more overseas companies, New York wants to do the same as well as poach from the Hub.